German Other Utilities Stock News

AIXTRON (XTRA:AIXA) has drawn fresh attention after its latest quarterly results showed lower sales and earnings, alongside a sharp rise in new orders linked to AI data center optoelectronics demand. See our latest analysis for AIXTRON. The latest earnings update has come after a volatile stretch for AIXTRON. The share price is now €36.27, with a 30 day share price return down 29.71% and a year to date share price return of 85.15%, while the 1 year total shareholder return of 152.17% shows...

Nemetschek stock closed at €58.05 going into the numbers, roughly flat over the past month and slightly weaker over three months. The headline today is about profitability, not price. Q2 basic earnings per share came in at €0.57 on revenue of €327.66m, with net income of €66.04m, extending a run that has lifted trailing twelve month earnings and margins over the past year. For a software group often judged on quality of profits and long term cash generation, this latest quarter keeps that...

Hensoldt heads into this earnings season with a stock that has already run hard, up double digits over the past month and sitting at €79.76 at the last close on 31 July 2026. That backdrop makes today’s sentiment all about one thing: the market is trying to square a premium P/E of 92.1x with an earnings release built around record order momentum and firmer profitability. The headline is not the latest quarterly earnings per share. It is the combination of record H1 order intake above €2.8b...

AlzChem Group stock has slipped over the past week and month, yet the latest earnings print tells a more resilient story than the recent price chart suggests. At around €153.9 a share, investors are reacting to shorter term noise while the chemistry specialist continues to put up solid profit per share and healthy net income. The headline this quarter is earnings power. Basic earnings per share for recent quarters sit comfortably above €1.70 and trailing net margins stand in the low double...

Siltronic heads into this earnings season with a stock that has slipped about 13% over the past month, even as semiconductor optimism around artificial intelligence has stayed loud. The headline from Q2 is not explosive growth or a sudden turnaround. It is instead a slow grind in margins set against a still loss making backdrop. Revenue in Q2 came in at €321.6m, while the company reported a loss of €52.1m on a net income basis and basic earnings per share of €1.71 in the red. The story for...

Novem Group stock closed at €2.66 after the Q1 print, with the price still reflecting a market that has treated this auto components specialist as a low-growth, loss making story. The headline from these numbers is different. Revenue reached €133.3m and, more importantly, Novem moved back into the black with €1.6m of net income from continuing operations. For a company that has been unprofitable over the last twelve months and carries pressure on interest coverage, that shift back to earnings...

KION GROUP stock has sagged over the past quarter, with the share price down about 12% over 90 days, yet Q2 landed with a cleaner story than the chart suggests. The stock closed at €38.93 on 31 July while earnings per share for the quarter came in at about €0.86 on revenue of €2.92b. The key focus is margin resilience and earnings recovery, which feed into a trailing P/E of 13.2x that sits well below both the German machinery industry and peer averages. Short term sentiment looks tired, but...

HOCHTIEF (XTRA:HOT) has lifted its 2026 operational net profit guidance following what it describes as positive business performance, citing Turner and strong data center related demand as key contributors. See our latest analysis for HOCHTIEF. The latest guidance upgrade and strong order intake sit against a mixed recent share price pattern for HOCHTIEF, with the 1 month share price return down 10.72% and the 1 year total shareholder return at 141.31%. This indicates that long term momentum...

The market has treated Villeroy & Boch like a slow burn income stock, yet the share price has slipped about 11% over three months coming into these Q2 numbers and closed at €15.60 on 31 July. The headline this quarter is not revenue, which sat at €317.1m. It is the swing into a €10m net loss and the fact that the trailing twelve months are now loss making. For a company often viewed through its low P/S multiple and generous 5.45% dividend, that profit squeeze is the real story investors will...

Wacker Chemie stock comes into this earnings day on the back foot, with the share price down roughly 5% over the past three months and trading near €88.5 at the latest close. The headline shock is not the top line. It is the profit swing. Net income in Q2 2026 sits at €340.8m, helped by a Siltronic related gain, and basic earnings per share jump to €6.84 from €0.21 in Q1. The market now has to decide whether this sharp profit recovery reflects a healthier chemicals business or a one quarter...

Knorr-Bremse stock has barely moved over the past month and sits at €102.90, yet the latest earnings landed with far more energy than the share price suggests. Q2 brought total revenue of €2,164m and basic earnings per share of €1.08, which keeps the trailing price to earnings multiple at 28.4x. The real story is the tension between a premium P/E and a stock that still trades well below one popular fair value estimate. Today’s muted reaction appears more like investors hesitating at the...

TAKKT has been trading like a deep value story that just will not turn, with the stock down about 16% over the past three months and closing at €2.29 before this latest report. The headline from Q2 is not about growth. It is about another quarter in the red, with a net loss of €5.2 million on €228.3 million of revenue and a continued loss per share. The key issue now is whether the valuation gap that attracted bargain hunters still looks compelling once this ongoing earnings pressure is taken...

Heidelberg Materials went into this earnings release with a stock that had drifted down roughly 4% over the past week and about 15% over three months. Yet the H1 report told a calmer story. Trailing twelve month net income of €2.03b and a net margin of 9.3% sit alongside a P/E of 13.9, which is below both the wider European basic materials group and direct peers. The market is trading the short term mood, while the main point of focus today is valuation versus a still solid profit...

Drägerwerk KGaA stock has quietly re‑rated over the past month, with a roughly 31% gain taking the shares to about €109.4 into this earnings print. The headline is simple: profitability is now the story. Q2 revenue of €847.3m came with a clear earnings step up, and group EBIT for the first half more than tripled to about €64m, helped by firmer margins. For a medical and safety technology group that lives or dies on cash generation and balance sheet resilience, the shift to positive free cash...

adidas stock is coming into this print on the back foot, down about 8% over the past week and roughly 12% over the past month, which tells you sentiment was already fragile before the numbers hit. The results themselves center on one thing that cuts through the noise. Q2 delivered adidas’s highest quarterly revenue on record at €6.7b, helped by a gross margin around 52%. The market’s recent chill on the stock now sits against an earnings report built on volume, pricing power and a very full...

Ceconomy stock came into this earnings print with mixed sentiment. The share price sits at €4.01 after a flat week and a modest gain over the past month, while the 90 day return is still in decline. The headline from this quarter is clear. Revenue of €5,273m could not prevent another quarterly loss, with basic earnings per share of €0.14 in the red and net income excluding extra items also in loss territory. Is Ceconomy a genuine low P/S opportunity, or does the DCF gap signal a value trap...

The market has BMW trading at €59.22 after a flat week and a sharp 3 month slide, yet the latest earnings hinge on something the price is not fully reflecting. The headline is profit pressure. Quarterly net income sits at €1,236m against €1,622m in Q1, even as revenue holds around €31.3b. That is a margin squeeze story, not a collapse in demand. Today is about whether that pressure is a blip linked to restructuring and China or a reset in BMW’s earning power. The rest of this report unpacks...

MTU Aero Engines entered the Q2 print with the stock sitting near €361.8, a level that already reflected a strong 90 day run and a softer 30 day patch. The headline from the quarter is clear. Revenue reached €2.435b while net income came in at €230m, and free cash flow over the first half of 2026 stood at €294m. For an aerospace engine and maintenance specialist, the story this time is about cash. The raised cash conversion guidance and solid first half cash generation are what really...

Symrise stock entered this H1 report with a 90-day gain of about 18.7% and a flat month behind it. This means expectations were quietly reset higher even before the numbers were released. The headline is not revenue in this flavour and fragrance specialist; it is profitability. Trailing net profit margin now sits at 5%, roughly half the 10.2% level reported a year earlier, while the P/E multiple stands at 49.6x versus industry averages near 20x. Short-term optimism now meets a longer-term...

SNP Schneider-Neureither & Partner stock closed at €81.8 after the Q2 print, barely moved over the past week and still weaker over the last three months. The muted reaction sits against earnings that keep pushing higher net income and earnings per share, with Q2 net profit at €11.026m. The bigger story sits beyond this quarter. Trailing earnings are much stronger than a year ago, yet analyst models point to slightly declining earnings over the next three years even as revenue is forecast to...

Third quarter earnings and guidance shift put Siemens Healthineers in focus Siemens Healthineers (XTRA:SHL) is back on investors’ radar after third quarter results, a guidance tweak linked to tariff refunds, and fresh value partnerships in the United States. The company reported third quarter sales of €5,764 million and net income of €669 million, with basic earnings per share from continuing operations of €0.60. Imaging and Precision Therapy segments were highlighted alongside ongoing...

AlzChem Group (XTRA:ACT) has drawn fresh attention after reporting second quarter and first half 2026 results, with both sales and net income higher than the same periods a year earlier. See our latest analysis for AlzChem Group. Despite the stronger first half of 2026 results, AlzChem Group’s share price has fallen 11.6% over the past day and is down 12.3% over the past week, although the 5 year total shareholder return of over 6x points to a much stronger longer term picture. If this...

RENK Group (XTRA:R3NK) has completed a major refinancing, replacing its leveraged buyout debt with a €1.05b unsecured syndicated loan package. This change in capital structure is central to the company’s current stock story. See our latest analysis for RENK Group. RENK Group’s refinancing news comes after a mixed price pattern, with the share price up about 13% over the past 30 days but down about 12% over 90 days and the one year total shareholder return down about 29%. The recent short term...

Befesa stock went into this earnings day with a mixed mood. The price is roughly flat over the past week but up about 16% over the past month, which suggests expectations had already crept higher. The headline is simple. Q2 net income of €24.3m and basic earnings per share of €0.61 point to a cleaner margin story that aligns with the recent improvement in trailing net profit margin to 7.3%. The question now is whether that margin strength justifies a P/E of 16.2x when the wider European...